191 related articles for article (PubMed ID: 28125074)
1. Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands.
van Wanrooij RL; Bouma G; Bontkes HJ; Neefjes-Borst A; van Grieken NC; von Blomberg BM; Mulder CJ
Clin Transl Gastroenterol; 2017 Jan; 8(1):e218. PubMed ID: 28125074
[TBL] [Abstract][Full Text] [Related]
2. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
[TBL] [Abstract][Full Text] [Related]
4. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
[TBL] [Abstract][Full Text] [Related]
5. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
[TBL] [Abstract][Full Text] [Related]
6. T-cell repertoires in refractory coeliac disease.
Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
[TBL] [Abstract][Full Text] [Related]
7. Approach to patients with refractory coeliac disease.
Nasr I; Nasr I; Campling H; Ciclitira PJ
F1000Res; 2016; 5():. PubMed ID: 27803799
[TBL] [Abstract][Full Text] [Related]
8. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
[TBL] [Abstract][Full Text] [Related]
9. Clinical staging and survival in refractory celiac disease: a single center experience.
Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
[TBL] [Abstract][Full Text] [Related]
10. Splenic volume differentiates complicated and non-complicated celiac disease.
van Gils T; Nijeboer P; van Waesberghe JHT; Coupé VM; Janssen K; Zegers JA; Nurmohamed SA; Kraal G; Jiskoot SC; Bouma G; Mulder CJ
United European Gastroenterol J; 2017 Apr; 5(3):374-379. PubMed ID: 28507749
[TBL] [Abstract][Full Text] [Related]
11. The incidence and clinical spectrum of refractory celiac disease in a north american referral center.
Roshan B; Leffler DA; Jamma S; Dennis M; Sheth S; Falchuk K; Najarian R; Goldsmith J; Tariq S; Schuppan D; Kelly CP
Am J Gastroenterol; 2011 May; 106(5):923-8. PubMed ID: 21468013
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
[TBL] [Abstract][Full Text] [Related]
13. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
Chander U; Leeman-Neill RJ; Bhagat G
Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
[TBL] [Abstract][Full Text] [Related]
16. Refractory celiac disease and its mimickers: a review on pathogenesis, clinical-pathological features and therapeutic challenges.
Scarmozzino F; Pizzi M; Pelizzaro F; Angerilli V; Dei Tos AP; Piazza F; Savarino EV; Zingone F; Fassan M
Front Oncol; 2023; 13():1273305. PubMed ID: 38023263
[TBL] [Abstract][Full Text] [Related]
17. Decreased circulating iNKT cell numbers in refractory coeliac disease.
Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
[TBL] [Abstract][Full Text] [Related]
18. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
[TBL] [Abstract][Full Text] [Related]
19. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
20. An unexpected deterrent in diagnosing refractory celiac disease and enteropathy-associated T-cell lymphoma: a gluten-free diet.
Hussain N; Hussain F; Chatterjee T; Upalakalin JN; Lynch T
J Community Hosp Intern Med Perspect; 2018; 8(4):233-236. PubMed ID: 30181834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
